2022-04-012023-03-312023-03-31false02332105VANDAGRAPH LIMITED2023-11-20iso4217:GBPxbrli:pure023321052022-04-01023321052023-03-31023321052022-04-012023-03-31023321052021-04-01023321052022-03-31023321052021-04-012022-03-3102332105bus:SmallEntities2022-04-012023-03-3102332105bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3102332105bus:FullAccounts2022-04-012023-03-3102332105bus:PrivateLimitedCompanyLtd2022-04-012023-03-3102332105core:WithinOneYear2023-03-3102332105core:AfterOneYear2023-03-3102332105core:WithinOneYear2022-03-3102332105core:AfterOneYear2022-03-3102332105core:ShareCapital2023-03-3102332105core:SharePremium2023-03-3102332105core:RevaluationReserve2023-03-3102332105core:OtherReservesSubtotal2023-03-3102332105core:RetainedEarningsAccumulatedLosses2023-03-3102332105core:ShareCapital2022-03-3102332105core:SharePremium2022-03-3102332105core:RevaluationReserve2022-03-3102332105core:OtherReservesSubtotal2022-03-3102332105core:RetainedEarningsAccumulatedLosses2022-03-3102332105core:LandBuildings2023-03-3102332105core:PlantMachinery2023-03-3102332105core:Vehicles2023-03-3102332105core:FurnitureFittings2023-03-3102332105core:OfficeEquipment2023-03-3102332105core:NetGoodwill2023-03-3102332105core:IntangibleAssetsOtherThanGoodwill2023-03-3102332105core:ListedExchangeTraded2023-03-3102332105core:UnlistedNon-exchangeTraded2023-03-3102332105core:LandBuildings2022-03-3102332105core:PlantMachinery2022-03-3102332105core:Vehicles2022-03-3102332105core:FurnitureFittings2022-03-3102332105core:OfficeEquipment2022-03-3102332105core:NetGoodwill2022-03-3102332105core:IntangibleAssetsOtherThanGoodwill2022-03-3102332105core:ListedExchangeTraded2022-03-3102332105core:UnlistedNon-exchangeTraded2022-03-3102332105core:LandBuildings2022-04-012023-03-3102332105core:PlantMachinery2022-04-012023-03-3102332105core:Vehicles2022-04-012023-03-3102332105core:FurnitureFittings2022-04-012023-03-3102332105core:OfficeEquipment2022-04-012023-03-3102332105core:NetGoodwill2022-04-012023-03-3102332105core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3102332105core:ListedExchangeTraded2022-04-012023-03-3102332105core:UnlistedNon-exchangeTraded2022-04-012023-03-3102332105core:MoreThanFiveYears2022-04-012023-03-3102332105core:Non-currentFinancialInstruments2023-03-3102332105core:Non-currentFinancialInstruments2022-03-3102332105dpl:CostSales2022-04-012023-03-3102332105dpl:DistributionCosts2022-04-012023-03-3102332105core:LandBuildings2022-04-012023-03-3102332105core:PlantMachinery2022-04-012023-03-3102332105core:Vehicles2022-04-012023-03-3102332105core:FurnitureFittings2022-04-012023-03-3102332105core:OfficeEquipment2022-04-012023-03-3102332105dpl:AdministrativeExpenses2022-04-012023-03-3102332105core:NetGoodwill2022-04-012023-03-3102332105core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3102332105dpl:GroupUndertakings2022-04-012023-03-3102332105dpl:ParticipatingInterests2022-04-012023-03-3102332105dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3102332105core:ListedExchangeTraded2022-04-012023-03-3102332105dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3102332105core:UnlistedNon-exchangeTraded2022-04-012023-03-3102332105dpl:CostSales2021-04-012022-03-3102332105dpl:DistributionCosts2021-04-012022-03-3102332105core:LandBuildings2021-04-012022-03-3102332105core:PlantMachinery2021-04-012022-03-3102332105core:Vehicles2021-04-012022-03-3102332105core:FurnitureFittings2021-04-012022-03-3102332105core:OfficeEquipment2021-04-012022-03-3102332105dpl:AdministrativeExpenses2021-04-012022-03-3102332105core:NetGoodwill2021-04-012022-03-3102332105core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3102332105dpl:GroupUndertakings2021-04-012022-03-3102332105dpl:ParticipatingInterests2021-04-012022-03-3102332105dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3102332105core:ListedExchangeTraded2021-04-012022-03-3102332105dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3102332105core:UnlistedNon-exchangeTraded2021-04-012022-03-3102332105core:NetGoodwill2023-03-3102332105core:IntangibleAssetsOtherThanGoodwill2023-03-3102332105core:LandBuildings2023-03-3102332105core:PlantMachinery2023-03-3102332105core:Vehicles2023-03-3102332105core:FurnitureFittings2023-03-3102332105core:OfficeEquipment2023-03-3102332105core:AfterOneYear2023-03-3102332105core:WithinOneYear2023-03-3102332105core:ListedExchangeTraded2023-03-3102332105core:UnlistedNon-exchangeTraded2023-03-3102332105core:ShareCapital2023-03-3102332105core:SharePremium2023-03-3102332105core:RevaluationReserve2023-03-3102332105core:OtherReservesSubtotal2023-03-3102332105core:RetainedEarningsAccumulatedLosses2023-03-3102332105core:NetGoodwill2022-03-3102332105core:IntangibleAssetsOtherThanGoodwill2022-03-3102332105core:LandBuildings2022-03-3102332105core:PlantMachinery2022-03-3102332105core:Vehicles2022-03-3102332105core:FurnitureFittings2022-03-3102332105core:OfficeEquipment2022-03-3102332105core:AfterOneYear2022-03-3102332105core:WithinOneYear2022-03-3102332105core:ListedExchangeTraded2022-03-3102332105core:UnlistedNon-exchangeTraded2022-03-3102332105core:ShareCapital2022-03-3102332105core:SharePremium2022-03-3102332105core:RevaluationReserve2022-03-3102332105core:OtherReservesSubtotal2022-03-3102332105core:RetainedEarningsAccumulatedLosses2022-03-3102332105core:NetGoodwill2021-04-0102332105core:IntangibleAssetsOtherThanGoodwill2021-04-0102332105core:LandBuildings2021-04-0102332105core:PlantMachinery2021-04-0102332105core:Vehicles2021-04-0102332105core:FurnitureFittings2021-04-0102332105core:OfficeEquipment2021-04-0102332105core:AfterOneYear2021-04-0102332105core:WithinOneYear2021-04-0102332105core:ListedExchangeTraded2021-04-0102332105core:UnlistedNon-exchangeTraded2021-04-0102332105core:ShareCapital2021-04-0102332105core:SharePremium2021-04-0102332105core:RevaluationReserve2021-04-0102332105core:OtherReservesSubtotal2021-04-0102332105core:RetainedEarningsAccumulatedLosses2021-04-0102332105core:AfterOneYear2022-04-012023-03-3102332105core:WithinOneYear2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3102332105core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3102332105core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3102332105core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3102332105core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3102332105core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3102332105core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3102332105core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3102332105core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3102332105core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3102332105core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3102332105core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3102332105bus:Director12022-04-012023-03-3102332105bus:Director22022-04-012023-03-31

VANDAGRAPH LIMITED

Registered Number
02332105
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

VANDAGRAPH LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

LAMB, Derek Iain
LAMB, Georgeina Greenfield

Registered Address

15 Station Road
Cross Hills
Keighley
BD20 7DT

Registered Number

02332105 (England and Wales)
VANDAGRAPH LIMITED
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets61,815543
1,815543
Current assets
Stocks8140,96594,080
Debtors933,34888,263
Cash at bank and on hand77,828103,331
252,141285,674
Creditors amounts falling due within one year10(23,029)(34,564)
Net current assets (liabilities)229,112251,110
Total assets less current liabilities230,927251,653
Net assets230,927251,653
Capital and reserves
Called up share capital22
Profit and loss account230,925251,651
Shareholders' funds230,927251,653
The financial statements were approved and authorised for issue by the Board of Directors on 20 November 2023, and are signed on its behalf by:
LAMB, Georgeina Greenfield
Director
Registered Company No. 02332105
VANDAGRAPH LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Principal activities
The principal activity of the company is the sale of oxygen equipment for diving.
3.Basis of measurement used in financial statements
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
4.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows: Office Equipment - 33% on cost Plant and Machinery - 5% Straight line
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to the Income Statement
Valuation of financial instruments policy
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Going concern
The directors believe that the company has adequate resources to continue in operational existence for the foreseeable future. The company continues to have the support of the directors, shareholders and creditors and therefore continue to adopt the going concern basis of accounting in preparing the financial statements.
5.Employee information

20232022
Average number of employees during the year22
6.Property, plant and equipment

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 22-2,1462,146
Additions1,541-1,541
At 31 March 231,5412,1463,687
Depreciation and impairment
At 01 April 22-1,6031,603
Charge for year13256269
At 31 March 23131,8591,872
Net book value
At 31 March 231,5282871,815
At 31 March 22-543543
7.Description of nature of transactions and balances with related parties
The company operates rent free from premises owned by Viamed Limited. Included within debtors due within one year is a loan to Viamed Limited, a company with common directors and shareholders, of £Nil (2022 - £50,000). This amount is interest free and repayable on demand.
8.Stocks
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete). At each date of Statement of Financial Position, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to completed the sale. The impairment loss is recognised immediately in the Income Statement.

2023

2022

££
Other stocks140,96594,080
Total140,96594,080
9.Debtors

2023

2022

££
Trade debtors / trade receivables22,39125,009
Amounts owed by group undertakings-50,000
Other debtors10,95713,254
Total33,34888,263
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
10.Creditors within one year

2023

2022

££
Trade creditors / trade payables4,90318,565
Taxation and social security11,1268,999
Accrued liabilities and deferred income7,0007,000
Total23,02934,564
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.